Translating
Ideas to
Therapies
We are a groundbreaking immunotherapy venture studio fund focused on company creation. We accelerate early-stage R&D and build drug discovery programs to cure diseases across autoimmunity, inflammation, and immuno-oncology.
Immunotherapy
with Impact
Our studio of experienced, immunology-focused drug developers enhances value creation by forming multiple, thematically aligned startups to develop and commercialize immunotherapeutics. We partner with university-based collaborators to extend novel and untapped fundamental biological observations, create proof-of-concept data, and generate advanced development candidate packages using our expertise and internal laboratories.
Immune-Based Diseases
A dysfunctional immune system is increasingly being recognized as a key factor, if not the factor, in the causal development and maintenance of a broad spectrum of diseases from cancer to infectious, autoimmune, and inflammatory diseases
About Us
Concept to Therapy
We focus on more efficiently developing and validating drug concepts into advanced development candidate packages that can be spun out into biotech companies or acquired by pharmaceutical companies for clinical development.
Our Studio
Immune Archetype-Driven
We are propelled by deep immune phenotyping datasets (Immune Archetype Platform), developed by Max Krummel and colleagues. We utilize AI and modern machine learning to characterize and compare the immune states in health and disease, provide key insights into the cause and consequence of disease, and to interconvert the immune system of a particular tissue from disease to healthy.
Our Science